$TGTX News Article - TG Therapeutics Announces FDA Acceptance of New Drug Application for Umbralisib as a Treatment for Patients with Previously Treated Marginal Zone Lymphoma and Follicular Lymphoma
https://marketwirenews.com/news-releases/tg-t...88806.html